Medullary Thyroid Cancer – Feature Review and Update on Systemic Treatment
Medullary thyroid carcinoma (MTC) is a rare malignancy that originates from parafollicular (C cells) of the thyroid and accounts for 2-4% of all thyroid malignancies. MTC may be sporadic or inherited, the latter as part of the MEN 2 syndromes. Germline mutations in the RET proto-oncogene (REarran...
Main Authors: | Nina Dabelić, Tomislav Jukić, Ana Fröbe |
---|---|
Format: | Article |
Language: | English |
Published: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2020-01-01
|
Series: | Acta Clinica Croatica |
Subjects: | |
Online Access: | https://hrcak.srce.hr/file/360851 |
Similar Items
-
A Brief Review on The Molecular Basis of Medullary Thyroid Carcinoma
by: Mohammadi Masoumeh, et al.
Published: (2016-11-01) -
Germline mutation of exon 19 of RET proto-oncogene in an Iranian population with Medullary thyroid cancer
by: Hoda Golab Ghadaksaz, et al.
Published: (2015-09-01) -
MEDULLARY THYROID CANCER AS PART OF MEN 2B SYNDROME. CASE REPORT
by: L. N. Lyubchenko, et al.
Published: (2015-04-01) -
Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid Carcinoma.
by: Sara Sheikholeslami, et al.
Published: (2014-02-01) -
Plasma levels of calcitonin in medullary thyroid carcinoma patients with and without the RET proto-oncogene mutations in exons 10 and 11
by: Samira Ehyayi, et al.
Published: (2017-09-01)